The European Medicines Agency is preparing to approve the Moderna vaccine today

A second coronavirus vaccine is on its way to the EU, hoping to help speed up the vaccination program in the countries of the Union.

The European Medicines Agency (EMA) is meeting today and will probably give the green light to the Moderna vaccine as it did not approve it on Monday, asking for more information from the American biotechnology company. “This process is taking place under a lot of time pressure,” de Ber , chairman of the Dutch Drug Evaluation Committee, said after Monday’s meeting . “And if all the questions have not been answered enough, then maybe it will last longer.”

Europe urgently needs a second vaccine after that of the BioNTech / Pfizer as the pandemic rages on and anxiety intensifies as the two new coronavirus strains spread to the Old Continent, first located in Britain and South Africa. , although BioNTech says it is not worried .

At the same time, criticism of the Commission and various governments of the Member States is escalating to the pace at which vaccinations are proceeding. “I fully understand the concern, but I have always said that a safe and effective vaccine will not be a magic wand. “The approval of the BioNTech / Pfizer vaccine was not a magic wand, nor will it be the approval of the Moderna vaccine ,” EU Health Commissioner Stella Kyriakidou told Politico , noting that the distribution of the vaccine will take time as manufacturers struggle to accelerate production and Member States coordinate mass vaccination.

Effective 94% Moderna vaccine does not require dry ice storage, like that of BioNTech / Pfizer, but is said to be more expensive than what the EU ordered, as the dose is around € 18, well over € 12 for the vaccine. BioNTech / Pfizer and the ten of CureVac. That may be why the Commission ordered fewer doses – 180 million vs. 300 million for Pfizer and 225 million for Curevac – with the option of buying another 180 million. But even if the Commission had ordered more doses, Moderna has limited production capacity in the EU and, as he said, could produce up to 20 million doses – all for the US. Moderna now says it can prepare between 500 and 600 million doses by the end of 2021 for worldwide distribution,

Source – 

Leave a Reply

Your email address will not be published.

error: Content is protected !!